46 results on '"Geisbert, Thomas W."'
Search Results
2. Marburg and Ravn Viruses Fail to Cause Disease in the Domestic Ferret ( Mustela putorius furo )
3. Efficacy of Human Monoclonal Antibody Monotherapy Against Bundibugyo Virus Infection in Nonhuman Primates
4. Comparative Transcriptomics in Ebola Makona-Infected Ferrets, Nonhuman Primates, and Humans
5. Role of Antibodies in Protection Against Ebola Virus in Nonhuman Primates Immunized With Three Vaccine Platforms
6. Postexposure Efficacy of Recombinant Vesicular Stomatitis Virus Vectors Against High and Low Doses of Marburg Virus Variant Angola in Nonhuman Primates
7. The Host Response to Smallpox: Analysis of the Gene Expression Program in Peripheral Blood Cells in a Nonhuman Primate Model
8. Reverse Genetics with a Full-Length Infectious cDNA of Severe Acute Respiratory Syndrome Coronavirus
9. An Outbreak of Ebola Virus Disease in the Lassa Fever Zone
10. Field Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
11. Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood
12. Oral and Conjunctival Exposure of Nonhuman Primates to Low Doses of Ebola Makona Virus
13. Passive Immunotherapy: Assessment of Convalescent Serum Against Ebola Virus Makona Infection in Nonhuman Primates
14. Analytical Validation of the ReEBOV Antigen Rapid Test for Point-of-Care Diagnosis of Ebola Virus Infection
15. The Domestic Ferret (Mustela putorius furo) as a Lethal Infection Model for 3 Species of Ebolavirus
16. Monoclonal antibody therapy for Junin virus infection
17. Development of Prototype Filovirus Recombinant Antigen Immunoassays
18. Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model
19. Lack of Marburg Virus Transmission From Experimentally Infected to Susceptible In-Contact Egyptian Fruit Bats
20. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus
21. Considerations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection
22. Stat1-Deficient Mice Are Not an Appropriate Model for Efficacy Testing of Recombinant Vesicular Stomatitis Virus-Based Filovirus Vaccines
23. A Single-Vector, Single-Injection Trivalent Filovirus Vaccine: Proof of Concept Study in Outbred Guinea Pigs
24. Modeling the Disease Course of Zaire ebolavirus Infection in the Outbred Guinea Pig
25. Protection Against Lethal Marburg Virus Infection Mediated by Lipid Encapsulated Small Interfering RNA
26. Interferon-β Therapy Prolongs Survival in Rhesus Macaque Models of Ebola and Marburg Hemorrhagic Fever
27. A Recently Isolated Lassa Virus From Mali Demonstrates Atypical Clinical Disease Manifestations and Decreased Virulence in Cynomolgus Macaques
28. Antibodies are necessary for rVSV/ZEBOV-GP–mediated protection against lethal Ebola virus challenge in nonhuman primates
29. Pathogenesis of Marburg Hemorrhagic Fever in Cynomolgus Macaques
30. Single Immunization With a Monovalent Vesicular Stomatitis Virus-Based Vaccine Protects Nonhuman Primates Against Heterologous Challenge With Bundtbugyo ebolavirus
31. Management of Accidental Exposure to Ebola Virus in the Biosafety Level 4 Laboratory, Hamburg, Germany
32. Vesicular Stomatitis Virus-Based Ebola Vaccines With Improved Cross-Protective Efficacy
33. Therapeutics of Ebola Hemorrhagic Fever: Whole–Genome Transcriptional Analysis of Successful Disease Mitigation
34. Recombinant Vesicular Stomatitis Virus-Based Vaccines Against Ebola and Marburg Virus Infections
35. In vitro and in vivo Characterization of Recombinant Ebola Viruses Expressing Enhanced Green Fluorescent Protein
36. Outbreaks of Filovirus Hemorrhagic Fever: Time to Refocus on the Patient
37. Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2
38. Epitopes Required for Antibody-Dependent Enhancement of Ebola Virus Infection
39. Ebola Hemorrhagic Fever: Evaluation of Passive Immunotherapy in Nonhuman Primates
40. Lymphocyte Death in a Mouse Model of Ebola Virus Infection
41. Recombinant Human Activated Protein C for the Postexposure Treatment of Ebola Hemorrhagic Fever
42. Pathologic Findings Associated with Delayed Death in Nonhuman Primates Experimentally Infected with Zaire Ebola Virus
43. Postexposure Protection of Guinea Pigs against a Lethal Ebola Virus Challenge Is Conferred by RNA Interference
44. Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event
45. Pathogenesis of Experimental Ebola Virus Infection in Guinea Pigs
46. Ebola (Subtype Reston) Virus among Quarantined Nonhuman Primates Recently Imported from the Philippines to the United States
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.